Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics
Rare cancers (RCs), which account for over 20% of cancer cases, face significant research
and treatment challenges due to their limited prevalence. This results in suboptimal …
and treatment challenges due to their limited prevalence. This results in suboptimal …
Personalized chordoma organoids for drug discovery studies
A Al Shihabi, A Davarifar, HTL Nguyen, N Tavanaie… - Science …, 2022 - science.org
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …